Zepp Health (ZEPP) has had the highest return since January 1, 2025 by a small-cap US stock, returning 1,325.8%.
| ASSET | % RETURN |
|---|---|
Zepp Health (ZEPP) | 1,325.77% |
Oncology Institute (TOI) | 1,285.62% |
DeFi Development (DFDV) | 1,186.97% |
Newegg Commerce (NEGG) | 872.13% |
180 Life Sciences (ATNF) | 838.55% |
Better Home & Finance (BETR) | 608.79% |
Palvella Therapeutics (PVLA) | 546.51% |
Nanobiotix (NBTX) | 521.54% |
ThredUp (TDUP) | 445.83% |
Inhibrx Biosciences (INBX) | 435.53% |
I-Mab (IMAB) | 405.88% |
IsoEnergy (ISOU) | 364.17% |
Avino Silver & Gold Mines (ASM) | 363.74% |
Lightbridge (LTBR) | 358.1% |
So-Young International (SY) | 349.5% |
American Resources Corp Class A (AREC) | 338.89% |
DBV Technologies (DBVT) | 336.47% |
Galectin Therapeutics (GALT) | 332.82% |
Claritev (CTEV) | 320.54% |
Amprius Technologies (AMPX) | 320.14% |
CytomX Therapeutics (CTMX) | 304.95% |
Xunlei Ltd Adr (XNET) | 296.08% |
Nutex Health (NUTX) | 295.6% |
NioCorp Developments Ltd Common Stock (NB) | 294.65% |
United States Antimony (UAMY) | 291.57% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
